mani
virus
use
replic
strategi
involv
translat
larg
polyprotein
cleav
viral
andor
cellular
proteas
sever
virus
sever
impact
human
health
around
globe
includ
hiv
hcv
dengu
viru
west
nile
viru
method
genom
organ
mani
benefit
viru
condens
genet
materi
well
tempor
spatial
regul
protein
activ
depend
polyprotein
cleavag
state
studi
polyprotein
precursor
necessari
fulli
understand
viral
infect
identifi
possibl
new
drug
target
howev
atom
structur
current
avail
present
structur
four
recent
polyprotein
precursor
virus
posit
sens
rna
genom
regulatori
mechan
viral
gene
express
vari
throughout
viru
world
one
wide
use
mechan
employ
evolutionarili
diverg
rna
dna
virus
alik
organ
multipl
gene
singl
open
read
frame
dna
virus
use
extens
altern
splice
express
viral
protein
need
although
except
ex
african
swine
fever
viru
almost
retrovirus
rna
virus
use
strategi
translat
open
read
frame
larg
precursor
polyprotein
cleav
viral
cellular
proteas
highli
regul
manner
virus
regul
gene
express
polyprotein
process
repres
import
group
includ
sever
import
human
pathogen
hiv
polioviru
rhinoviru
dengu
viru
hepat
c
viru
west
nile
viru
chikungunya
viru
sar
coronaviru
encod
translat
larg
viral
polyprotein
precursor
strategi
mani
benefit
viru
lifecycl
first
polyprotein
allow
compact
genom
elimin
addit
genet
featur
promot
enhanc
element
would
necessari
express
protein
individu
addit
differenti
cleavag
site
usag
coordin
regul
activ
lastli
protein
sometim
perform
altern
function
precursor
form
versu
matur
form
given
wide
preval
polyprotein
process
mani
viral
famili
surprisingli
structur
precleavag
polyprotein
intermedi
avail
structur
viral
protein
prior
cleavag
essenti
provid
greater
understand
regul
function
organ
viral
genom
review
four
recent
atom
structur
polyprotein
precursor
alphavirus
envelop
virus
togavirida
famili
whose
genom
consist
positivesens
rna
kb
cap
structur
polyadenosin
tail
figur
genom
contain
two
cistron
first
encod
viral
replic
machineri
nonstructur
protein
nsp
latter
contain
structur
protein
form
virion
particl
alphaviru
replic
machineri
compos
four
nonstructur
protein
express
one
two
polyprotein
caus
read
opal
codon
end
nonstructur
precursor
polyprotein
cleav
highli
regul
manner
proteas
cterminu
shortli
translat
cleavag
junction
occur
either
ci
tran
follow
junction
ci
cleavag
intermedi
preferenti
use
genom
rna
synthes
negativesens
intermedi
rna
final
cleavag
event
yield
fulli
matur
nsp
switch
templat
negativesens
rna
synthes
positivesens
genom
subgenom
rna
structur
uncleav
precursor
protein
sindbi
viru
span
proteas
domain
central
zincbind
domain
zbd
prozbd
recent
determin
prozbd
show
solvent
expos
inaccess
cleavag
site
locat
base
wide
cleft
figur
proteas
activ
site
away
cleavag
site
support
tran
cleavag
mechan
attempt
model
proteas
onto
cleavag
site
result
steric
clash
indic
access
cleavag
site
highli
regul
unknown
mechan
extens
buri
surfac
area
due
ringshap
structur
creat
encircl
figur
sever
previous
describ
mutat
confer
noncytopath
phenotyp
map
surfac
make
contact
implic
interact
viral
pathogenesi
alphaviru
lifecycl
local
nucleu
howev
mechan
dissoci
post
cleavag
unknown
potenti
rna
bind
surfac
extend
surfac
propos
hypothes
rna
bind
surfac
may
alter
cleavag
result
rna
templat
switch
occur
cleavag
polioviru
nonenvelop
viru
picornavirida
famili
positivesens
rna
genom
kb
polioviru
rna
lack
cap
structur
use
intern
ribosom
entri
site
ire
translat
initi
genom
contain
singl
open
read
frame
encod
structur
nonstructur
gene
larg
polyprotein
figur
simplic
protein
group
viral
capsid
protein
protein
involv
viral
genom
replic
protein
process
cleavag
polyprotein
perform
virusencod
proteas
precursor
polyprotein
made
proteas
viral
rna
polymeras
respons
genom
replic
effici
proteas
polymeras
activ
alter
depend
cleavag
state
polyprotein
preferenti
cleav
precursor
compar
matur
alon
polymeras
activ
inhibit
precursor
furthermor
promot
rna
synthesi
redistribut
cellular
arf
protein
involv
membran
traffick
activ
trigger
cleav
form
activ
highlight
import
polyprotein
cleavag
mechan
gene
regul
atom
structur
resembl
beadsonastr
connect
flexibl
solvent
expos
linker
region
contain
cleavag
site
figur
overal
structur
alon
similar
counterpart
precursor
sharp
contrast
alphaviru
intramolecular
contact
structur
support
tran
cleavag
mechan
due
locat
proteas
activ
site
cleavag
site
post
cleavag
structur
ntermin
residu
fold
inward
insert
bind
pocket
particip
sever
hydrogen
bond
interact
residu
extend
structur
rearrang
ntermin
residu
post
cleavag
propos
mechan
activ
polymeras
activ
e
interact
cellular
receptor
contain
loop
respons
membran
fusion
express
precursor
protein
prm
prevent
prematur
fusion
e
cleav
furin
egress
releas
pr
fragment
result
matur
particl
addit
role
virion
morphogenesi
prm
precursor
may
assist
proper
fold
e
protein
construct
includ
prm
residu
eight
amino
acid
linker
place
transmembran
region
e
residu
mutat
furin
cleavag
site
pr
e
contain
three
distinct
domain
term
di
dii
diii
fusion
loop
locat
tip
dii
pr
peptid
novel
beta
barrel
fold
posit
distal
end
dii
block
fusion
loop
consist
role
prevent
membran
fusion
similar
inaccess
fusion
loop
immatur
viru
also
describ
chikungunya
structur
precursor
polyprotein
discuss
vaney
duquerroy
ray
current
issu
current
opinion
virolog
cryoelectron
microscopi
show
immatur
flavivirus
neutral
ph
spiki
appear
matur
flavivirus
smooth
surfac
appear
alter
depend
oligomer
state
immatur
prme
matur
e
protein
hing
angl
di
dii
e
alon
similar
hing
angl
prme
heterodim
howev
differ
angl
di
dii
immatur
versu
matur
viru
may
determin
oligomer
state
e
fit
xray
structur
cryoem
densiti
show
immatur
prme
neutral
ph
would
prevent
furin
cleavag
prm
due
steric
hindranc
egress
immatur
virion
transport
tran
golgi
network
exposur
acid
condit
caus
conform
chang
prme
allow
furin
access
cleavag
site
retrovirida
genom
consist
two
copi
positivesens
rna
revers
transcrib
earli
infect
result
dna
insert
host
genom
use
product
viral
rna
protein
infect
progress
retrovirus
vari
number
gene
encod
least
four
open
read
frame
gag
pro
pol
env
may
may
read
frame
hiv
retroviru
whose
genom
encod
nine
sometim
gene
gag
gene
locat
end
retroviru
genom
translat
polyprotein
precursor
contain
three
distinct
domain
matrix
capsid
ca
nucleocapsid
nc
figur
gag
precursor
associ
inner
surfac
cell
plasma
membran
particip
form
immatur
virion
select
packag
viral
rna
cleavag
precursor
protein
caus
matur
ca
protein
organ
conelik
structur
ultim
lead
matur
viru
discern
differ
immatur
matur
virion
structur
nmr
structur
ntermin
portion
immatur
gag
includ
ntermin
portion
ca
domain
ca
n
determin
figur
structur
ca
n
immatur
polyprotein
matur
post
cleavag
form
demonstr
nterminu
undergo
disord
order
transit
upon
cleavag
result
format
immatur
matur
structur
show
signific
chang
integr
residu
locat
ca
n
hairpin
region
previous
shown
prevent
proper
capsid
core
format
lead
format
noninfecti
viru
therefor
cleavag
trigger
format
ca
n
may
respons
proper
capsid
core
particl
assembl
present
four
recent
atom
structur
viral
polyprotein
precursor
sever
underli
mechan
viral
gene
regul
glean
structur
first
involv
access
polyprotein
cleavag
site
control
gene
activ
function
locat
specif
time
post
infect
cleavag
polyprotein
regul
differ
method
alphaviru
cleavag
site
solvent
expos
readili
access
proteas
requir
cleavag
still
unknown
access
polioviru
cleavag
site
postul
depend
intermolecular
scaffold
thought
form
molecul
cleavag
flaviviru
prme
regul
low
ph
environ
found
late
viral
egress
prevent
immatur
exposur
fusion
loop
secondli
cleavag
event
caus
conform
chang
newli
form
termini
matur
cleav
protein
permit
new
function
post
cleavag
polymeras
activ
initi
insert
nterminu
matur
protein
hydrophob
pocket
cleavag
nterminu
hiv
ca
undergo
format
result
matur
core
particl
structur
regard
viru
particl
matur
involv
precursor
protein
discuss
found
chikungunya
viru
viral
polyprotein
repres
larg
unexplor
structur
aspect
viral
lifecycl
especi
involv
viral
genom
replic
despit
preval
protein
throughout
viru
famili
viral
precursor
polyprotein
structur
current
avail
base
divers
four
structur
cleavag
site
regul
present
like
mani
regulatori
mechan
yet
describ
regulatori
role
rang
genom
replic
virion
matur
viral
polyprotein
valuabl
tool
design
uniqu
target
drug
